Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study

Abstract

Background Gender-related factors might affect vulnerability to Covid-19. The aim of this study was to describe the role of gender on clinical features and 28-day mortality in Covid-19 patients. Methods Observational study of Covid-19 patients hospitalized in Bergamo, Italy, during the first three weeks of the outbreak. Medical records, clinical, radiological and laboratory findings upon admission and treatment have been collected. Primary outcome was 28-day mortality since hospitalization. Results 431 consecutive adult patients were admitted. Female patients were 119 (27.6%) with a mean age of 67.0\u2009±\u200914.5\xa0years (vs 67.8\u2009±\u200912.5 for males, p \u2009=\u20090.54). Previous history of myocardial infarction, vasculopathy and former smoking habits were more common for males. At the time of admission PaO 2 /FiO 2 was similar between men and women (228 [IQR, 134–273] vs 238\xa0mmHg [150–281], p \u2009=\u20090.28). Continuous Positive Airway Pressure (CPAP) assistance was needed in the first 24\xa0h more frequently in male patients (25.7% vs 13.0%; p \u2009=\u20090.006). Overall 28-day mortality was 26.1% in women and 38.1% in men ( p\u2009 =\u20090.018). Gender did not result an independent predictor of death once the parameters related to disease severity at presentation were included in the multivariable analysis ( p \u2009=\u20090.898). Accordingly, the Kaplan–Meier survival analysis in female and male patients requiring CPAP or non-invasive ventilation in the first 24\xa0h did not find a significant difference ( p \u2009=\u20090.687). Conclusion Hospitalized women are less likely to die from Covid-19; however, once severe disease occurs, the risk of dying is similar to men. Further studies are needed to better investigate the role of gender in clinical course and outcome of Covid-19.